NCT03327038 Addressing Depression and Anxiety Symptoms in Patients With Inflammatory Bowel Disease Status UNKNOWN Phase NA
NCT03324334 Prevalence of Graves Disease in Patients With Ulcerative Colitis Status UNKNOWN Phase N/A
NCT03309865 Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis. Status WITHDRAWN Phase EARLY_PHASE1
NCT03301311 Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase NA
NCT03298022 Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC Status TERMINATED Phase PHASE2
NCT03290781 An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT03283085 A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) Status COMPLETED Phase PHASE3
NCT03282903 The PRognostic Effect of Environmental Factors in Crohn's and Colitis Status COMPLETED Phase N/A
NCT03281304 A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission Status TERMINATED Phase PHASE4
NCT03269695 Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. Status TERMINATED Phase PHASE2
NCT03268213 Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis Status COMPLETED Phase EARLY_PHASE1
NCT03266484 Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT03259334 Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis Status TERMINATED Phase PHASE3
NCT03259308 Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis Status TERMINATED Phase PHASE3
NCT03257345 VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT03251118 A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03239704 Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease Status UNKNOWN Phase NA
NCT03237260 An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis Status WITHDRAWN Phase PHASE4